Pharmacological Basis for the Use of Evodiamine in Alzheimer's Disease: Antioxidation and Antiapoptosis.

about

Pharmacological Basis for the Use of Evodiamine in Alzheimer's Disease: Antioxidation and Antiapoptosis.

Item

http://www.wikidata.org/entity/Q54976694

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pharmacological Basis for the ...... tioxidation and Antiapoptosis.

@en

Pharmacological Basis for the ...... tioxidation and Antiapoptosis.

@nl

type

Item

label

Pharmacological Basis for the ...... tioxidation and Antiapoptosis.

@en

Pharmacological Basis for the ...... tioxidation and Antiapoptosis.

@nl

prefLabel

Pharmacological Basis for the ...... tioxidation and Antiapoptosis.

@en

Pharmacological Basis for the ...... tioxidation and Antiapoptosis.

@nl

P1476

Pharmacological Basis for the ...... tioxidation and Antiapoptosis.

@en

P2093

Chunyue Wang

http://www.w3.org/2001/XMLSchema#string

Jiahui Lu

http://www.w3.org/2001/XMLSchema#string

Jiaqi Wang

http://www.w3.org/2001/XMLSchema#string

Jun Zhang

http://www.w3.org/2001/XMLSchema#string

Xin Liu

http://www.w3.org/2001/XMLSchema#string

Yongfeng Zhang

http://www.w3.org/2001/XMLSchema#string

Zhiping Li

http://www.w3.org/2001/XMLSchema#string

P2860

Pathways towards and away from Alzheimer's disease

Signaling pathways mTOR and AKT in epilepsy

Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration.

Alzheimer's disease: Targeting the Cholinergic System

Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis

Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

Oxidative damage and mitochondrial decay in aging.

Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins.

Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists.

P31

scholarly article

P356

10.3390/IJMS19051527

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Di Wang

P577

2018-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29883380

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5983845

http://www.w3.org/2001/XMLSchema#string